Donepezil 5.00 mg + Memantine Hydrochloride 5.00 mg

DONAMEM 5mg is a fixed-dose combination medication that contains Memantine Hydrochloride (5.00mg/Tablet) and Donepezil (5.00mg/Tablet). Memantine is an N-methyl-D-aspartate (NMDA) receptor antagonist, and Donepezil is an acetylcholinesterase inhibitor. This combination is used for the treatment of moderate to severe Alzheimer's disease. Memantine works by regulating the activity of glutamate, a neurotransmitter involved in cognitive functioning, while Donepezil inhibits the breakdown of acetylcholine, another neurotransmitter involved in memory and learning. Together, they help improve cognitive function, memory, and daily functioning in patients with Alzheimer's disease.

Take DONAMEM 5mg as directed by your doctor. The dosage may vary based on your medical condition and response to treatment. It is usually taken once daily, preferably at bedtime.

Allopathic

The contents and information provided here are solely intended to provide a general overview of the products and medicines and must be used for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. The information contained herein should not be used as a substitute for the advice of a qualified physician. For all queries or doubts related to your medical condition, we highly recommend that you consult your registered medical practitioner.